Orion Oyj ORNAV.HE Stock
Orion Oyj Price Chart
Orion Oyj ORNAV.HE Financial and Trading Overview
| Orion Oyj stock price | 33.6 EUR |
| Previous Close | 41.05 EUR |
| Open | 41.55 EUR |
| Bid | 41.15 EUR x 0 |
| Ask | 41.35 EUR x 0 |
| Day's Range | 41.2 - 41.55 EUR |
| 52 Week Range | 35.55 - 55 EUR |
| Volume | 359 EUR |
| Avg. Volume | 4.77K EUR |
| Market Cap | 5.42B EUR |
| Beta (5Y Monthly) | 0.47931 |
| PE Ratio (TTM) | 16.87755 |
| EPS (TTM) | 1.54 EUR |
| Forward Dividend & Yield | 1.6 (3.78%) |
| Ex-Dividend Date | March 23, 2023 |
| 1y Target Est | N/A |
ORNAV.HE Valuation Measures
| Enterprise Value | 5.92B EUR |
| Trailing P/E | 16.87755 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.0209417 |
| Price/Book (mrq) | 7.971853 |
| Enterprise Value/Revenue | 4.393 |
| Enterprise Value/EBITDA | 12.688 |
Trading Information
Orion Oyj Stock Price History
| Beta (5Y Monthly) | 0.47931 |
| 52-Week Change | 8.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 55 EUR |
| 52 Week Low | 35.55 EUR |
| 50-Day Moving Average | 42.66 EUR |
| 200-Day Moving Average | 45.79 EUR |
ORNAV.HE Share Statistics
| Avg. Volume (3 month) | 4.77K EUR |
| Avg. Daily Volume (10-Days) | 10.48K EUR |
| Shares Outstanding | 34.03M |
| Float | 127.46M |
| Short Ratio | N/A |
| % Held by Insiders | 32.69% |
| % Held by Institutions | 7.04% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.6 |
| Trailing Annual Dividend Yield | 3.89% |
| 5 Year Average Dividend Yield | 405.00% |
| Payout Ratio | 0.6695 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 24.92% |
| Operating Margin (ttm) | 31.37% |
| Gross Margin | 62.31% |
| EBITDA Margin | 34.62% |
Management Effectiveness
| Return on Assets (ttm) | 21.00% |
| Return on Equity (ttm) | 49.12% |
Income Statement
| Revenue (ttm) | 1.35B EUR |
| Revenue Per Share (ttm) | 9.6 EUR |
| Quarterly Revenue Growth (yoy) | 2.70% |
| Gross Profit (ttm) | 848.9M EUR |
| EBITDA | 466.7M EUR |
| Net Income Avi to Common (ttm) | 336M EUR |
| Diluted EPS (ttm) | 2.45 |
| Quarterly Earnings Growth (yoy) | -23.59% |
Balance Sheet
| Total Cash (mrq) | 99.8M EUR |
| Total Cash Per Share (mrq) | 0.71 EUR |
| Total Debt (mrq) | 210.6M EUR |
| Total Debt/Equity (mrq) | 28.93 EUR |
| Current Ratio (mrq) | 2.634 |
| Book Value Per Share (mrq) | 5.187 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 405M EUR |
| Levered Free Cash Flow (ttm) | -21912500 EUR |
Profile of Orion Oyj
| Country | Finland |
| State | N/A |
| City | Espoo |
| Address | Orionintie 1A |
| ZIP | 02200 |
| Phone | 358 10 4261 |
| Website | https://www.orion.fi |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 3564 |
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Precedex for intensive care sedative, as well as Fareston for breast cancer. The company also offers Salmeterol/fluticasone Easyhaler; Budesonide/formoterol Easyhaler; Formoterol Easyhaler; Budesonide Easyhaler; Beclomet Easyhaler; and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic and proprietary drugs, as well as provides contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. The company serves primarily healthcare services providers and professional, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics and laboratories. Further, it has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. The company was founded in 1917 and is headquartered in Espoo, Finland.
Q&A For Orion Oyj Stock
What is a current ORNAV.HE stock price?
Orion Oyj ORNAV.HE stock price today per share is 33.6 EUR.
How to purchase Orion Oyj stock?
You can buy ORNAV.HE shares on the Helsinki exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orion Oyj?
The stock symbol or ticker of Orion Oyj is ORNAV.HE.
Which industry does the Orion Oyj company belong to?
The Orion Oyj industry is Drug Manufacturers-General.
How many shares does Orion Oyj have in circulation?
The max supply of Orion Oyj shares is 138.49M.
What is Orion Oyj Price to Earnings Ratio (PE Ratio)?
Orion Oyj PE Ratio is 21.75324800 now.
What was Orion Oyj earnings per share over the trailing 12 months (TTM)?
Orion Oyj EPS is 1.54 EUR over the trailing 12 months.
Which sector does the Orion Oyj company belong to?
The Orion Oyj sector is Healthcare.
Orion Oyj ORNAV.HE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Helsinki Benchmark CAP_PI OMXHBCAPPI | 189.57 EUR 207.23 USD |
-0.24
|
— — | — — | — — | — - | — — |
| OMX Helsinki Health Care PI HX20PI | 1547.45 EUR 1691.57 USD |
-0.23
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI | 529.96 SEK 51.73 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI | 424.25 EUR 463.76 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX Helsinki_PI OMXHPI | 9903.21 EUR 10825.54 USD |
-0.22
|
— — | — — | — — | — - | — — |
| OMX Helsinki_GI OMXHGI | 31256.09 EUR 34167.13 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX Helsinki Cap_GI OMXHCAPGI | 26242.52 EUR 28686.62 USD |
-0.3
|
— — | — — | — — | — - | — — |
| OMX Helsinki Benchmark_GI OMXHBGI | 137.96 EUR 150.81 USD |
-0.15
|
— — | — — | — — | — - | — — |
| OMX Helsinki Benchmark CAP_GI OMXHBCAPGI | 563.54 EUR 616.02 USD |
-0.24
|
— — | — — | — — | — - | — — |
| OMX Helsinki Pharmaceuticals an HX201030PI | 1781.84 EUR 1947.79 USD |
-0.31
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 613.85 ISK 4.51 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 424.43 DKK 62.23 USD |
-0.09
|
— — | — — | — — | — - | — — |
| OMX_Helsinki_Large_Cap_PI OMXHLCPI | 107.62 EUR 117.64 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX Helsinki Cap_PI OMXHCAPPI | 7294.14 EUR 7973.48 USD |
-0.3
|
— — | — — | — — | — - | — — |
| OMX Helsinki Benchmark_PI OMXHBPI | 52.53 EUR 57.42 USD |
-0.15
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}